 | • レポートコード：QYR2104Z1084 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、犬幹細胞療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（同種幹細胞、自家幹細胞）、用途別市場規模（獣医病院、獣医クリニック、獣医研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・犬幹細胞療法の市場動向 ・企業の競争状況、市場シェア ・犬幹細胞療法の種類別市場規模（同種幹細胞、自家幹細胞） ・犬幹細胞療法の用途別市場規模（獣医病院、獣医クリニック、獣医研究所） ・犬幹細胞療法の北米市場規模2016-2027（アメリカ、カナダ） ・犬幹細胞療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・犬幹細胞療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・犬幹細胞療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・犬幹細胞療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（VETSTEM BIOPHARMA、Cell Therapy Sciences、Regeneus、Aratana Therapeutics、Medivet Biologics、Okyanos、Vetbiologics、VetMatrix、Magellan Stem Cells、ANIMAL CELL THERAPIES、Stemcellvet） ・結論 |
The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.
Market Analysis and Insights: Global Canine Stem Cell Therapy Market
The global Canine Stem Cell Therapy market size is projected to reach US$ 119.4 million by 2026, from US$ 100.7 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Canine Stem Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Canine Stem Cell Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Canine Stem Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Canine Stem Cell Therapy market.
Global Canine Stem Cell Therapy Scope and Market Size
Canine Stem Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Canine Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Allogeneic Stem Cells
Autologous Stem cells
Segment by Application
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Allogeneic Stem Cells
1.2.3 Autologous Stem cells
1.3 Market by Application
1.3.1 Global Canine Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Veterinary Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Canine Stem Cell Therapy Market Perspective (2016-2027)
2.2 Canine Stem Cell Therapy Growth Trends by Regions
2.2.1 Canine Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Canine Stem Cell Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Canine Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Canine Stem Cell Therapy Industry Dynamic
2.3.1 Canine Stem Cell Therapy Market Trends
2.3.2 Canine Stem Cell Therapy Market Drivers
2.3.3 Canine Stem Cell Therapy Market Challenges
2.3.4 Canine Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Stem Cell Therapy Players by Revenue
3.1.1 Global Top Canine Stem Cell Therapy Players by Revenue (2016-2021)
3.1.2 Global Canine Stem Cell Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Canine Stem Cell Therapy Revenue
3.4 Global Canine Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Canine Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2020
3.5 Canine Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Canine Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Canine Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Stem Cell Therapy Breakdown Data by Type
4.1 Global Canine Stem Cell Therapy Historic Market Size by Type (2016-2021)
4.2 Global Canine Stem Cell Therapy Forecasted Market Size by Type (2022-2027)
5 Canine Stem Cell Therapy Breakdown Data by Application
5.1 Global Canine Stem Cell Therapy Historic Market Size by Application (2016-2021)
5.2 Global Canine Stem Cell Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Canine Stem Cell Therapy Market Size (2016-2027)
6.2 North America Canine Stem Cell Therapy Market Size by Type
6.2.1 North America Canine Stem Cell Therapy Market Size by Type (2016-2021)
6.2.2 North America Canine Stem Cell Therapy Market Size by Type (2022-2027)
6.2.3 North America Canine Stem Cell Therapy Market Size by Type (2016-2027)
6.3 North America Canine Stem Cell Therapy Market Size by Application
6.3.1 North America Canine Stem Cell Therapy Market Size by Application (2016-2021)
6.3.2 North America Canine Stem Cell Therapy Market Size by Application (2022-2027)
6.3.3 North America Canine Stem Cell Therapy Market Size by Application (2016-2027)
6.4 North America Canine Stem Cell Therapy Market Size by Country
6.4.1 North America Canine Stem Cell Therapy Market Size by Country (2016-2021)
6.4.2 North America Canine Stem Cell Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Canine Stem Cell Therapy Market Size (2016-2027)
7.2 Europe Canine Stem Cell Therapy Market Size by Type
7.2.1 Europe Canine Stem Cell Therapy Market Size by Type (2016-2021)
7.2.2 Europe Canine Stem Cell Therapy Market Size by Type (2022-2027)
7.2.3 Europe Canine Stem Cell Therapy Market Size by Type (2016-2027)
7.3 Europe Canine Stem Cell Therapy Market Size by Application
7.3.1 Europe Canine Stem Cell Therapy Market Size by Application (2016-2021)
7.3.2 Europe Canine Stem Cell Therapy Market Size by Application (2022-2027)
7.3.3 Europe Canine Stem Cell Therapy Market Size by Application (2016-2027)
7.4 Europe Canine Stem Cell Therapy Market Size by Country
7.4.1 Europe Canine Stem Cell Therapy Market Size by Country (2016-2021)
7.4.2 Europe Canine Stem Cell Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Canine Stem Cell Therapy Market Size (2016-2027)
8.2 Asia-Pacific Canine Stem Cell Therapy Market Size by Type
8.2.1 Asia-Pacific Canine Stem Cell Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Canine Stem Cell Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Canine Stem Cell Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Canine Stem Cell Therapy Market Size by Application
8.3.1 Asia-Pacific Canine Stem Cell Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Canine Stem Cell Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Canine Stem Cell Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Canine Stem Cell Therapy Market Size by Region
8.4.1 Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Canine Stem Cell Therapy Market Size (2016-2027)
9.2 Latin America Canine Stem Cell Therapy Market Size by Type
9.2.1 Latin America Canine Stem Cell Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Canine Stem Cell Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Canine Stem Cell Therapy Market Size by Type (2016-2027)
9.3 Latin America Canine Stem Cell Therapy Market Size by Application
9.3.1 Latin America Canine Stem Cell Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Canine Stem Cell Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Canine Stem Cell Therapy Market Size by Application (2016-2027)
9.4 Latin America Canine Stem Cell Therapy Market Size by Country
9.4.1 Latin America Canine Stem Cell Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Canine Stem Cell Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Stem Cell Therapy Market Size (2016-2027)
10.2 Middle East & Africa Canine Stem Cell Therapy Market Size by Type
10.2.1 Middle East & Africa Canine Stem Cell Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Canine Stem Cell Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Canine Stem Cell Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Canine Stem Cell Therapy Market Size by Application
10.3.1 Middle East & Africa Canine Stem Cell Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Canine Stem Cell Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Canine Stem Cell Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Canine Stem Cell Therapy Market Size by Country
10.4.1 Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 VETSTEM BIOPHARMA
11.1.1 VETSTEM BIOPHARMA Company Details
11.1.2 VETSTEM BIOPHARMA Business Overview
11.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Introduction
11.1.4 VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.1.5 VETSTEM BIOPHARMA Recent Development
11.2 Cell Therapy Sciences
11.2.1 Cell Therapy Sciences Company Details
11.2.2 Cell Therapy Sciences Business Overview
11.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Introduction
11.2.4 Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.2.5 Cell Therapy Sciences Recent Development
11.3 Regeneus
11.3.1 Regeneus Company Details
11.3.2 Regeneus Business Overview
11.3.3 Regeneus Canine Stem Cell Therapy Introduction
11.3.4 Regeneus Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.3.5 Regeneus Recent Development
11.4 Aratana Therapeutics
11.4.1 Aratana Therapeutics Company Details
11.4.2 Aratana Therapeutics Business Overview
11.4.3 Aratana Therapeutics Canine Stem Cell Therapy Introduction
11.4.4 Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.4.5 Aratana Therapeutics Recent Development
11.5 Medivet Biologics
11.5.1 Medivet Biologics Company Details
11.5.2 Medivet Biologics Business Overview
11.5.3 Medivet Biologics Canine Stem Cell Therapy Introduction
11.5.4 Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.5.5 Medivet Biologics Recent Development
11.6 Okyanos
11.6.1 Okyanos Company Details
11.6.2 Okyanos Business Overview
11.6.3 Okyanos Canine Stem Cell Therapy Introduction
11.6.4 Okyanos Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.6.5 Okyanos Recent Development
11.7 Vetbiologics
11.7.1 Vetbiologics Company Details
11.7.2 Vetbiologics Business Overview
11.7.3 Vetbiologics Canine Stem Cell Therapy Introduction
11.7.4 Vetbiologics Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.7.5 Vetbiologics Recent Development
11.8 VetMatrix
11.8.1 VetMatrix Company Details
11.8.2 VetMatrix Business Overview
11.8.3 VetMatrix Canine Stem Cell Therapy Introduction
11.8.4 VetMatrix Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.8.5 VetMatrix Recent Development
11.9 Magellan Stem Cells
11.9.1 Magellan Stem Cells Company Details
11.9.2 Magellan Stem Cells Business Overview
11.9.3 Magellan Stem Cells Canine Stem Cell Therapy Introduction
11.9.4 Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.9.5 Magellan Stem Cells Recent Development
11.10 ANIMAL CELL THERAPIES
11.10.1 ANIMAL CELL THERAPIES Company Details
11.10.2 ANIMAL CELL THERAPIES Business Overview
11.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Introduction
11.10.4 ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.10.5 ANIMAL CELL THERAPIES Recent Development
11.11 Stemcellvet
11.11.1 Stemcellvet Company Details
11.11.2 Stemcellvet Business Overview
11.11.3 Stemcellvet Canine Stem Cell Therapy Introduction
11.11.4 Stemcellvet Revenue in Canine Stem Cell Therapy Business (2016-2021)
11.11.5 Stemcellvet Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Canine Stem Cell Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Allogeneic Stem Cells
Table 3. Key Players of Autologous Stem cells
Table 4. Global Canine Stem Cell Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Canine Stem Cell Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Canine Stem Cell Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Canine Stem Cell Therapy Market Share by Regions (2016-2021)
Table 8. Global Canine Stem Cell Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Canine Stem Cell Therapy Market Share by Regions (2022-2027)
Table 10. Canine Stem Cell Therapy Market Trends
Table 11. Canine Stem Cell Therapy Market Drivers
Table 12. Canine Stem Cell Therapy Market Challenges
Table 13. Canine Stem Cell Therapy Market Restraints
Table 14. Global Canine Stem Cell Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Canine Stem Cell Therapy Market Share by Players (2016-2021)
Table 16. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Stem Cell Therapy as of 2020)
Table 17. Ranking of Global Top Canine Stem Cell Therapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Canine Stem Cell Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Canine Stem Cell Therapy Product Solution and Service
Table 21. Date of Enter into Canine Stem Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Canine Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Canine Stem Cell Therapy Revenue Market Share by Type (2016-2021)
Table 25. Global Canine Stem Cell Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Canine Stem Cell Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Canine Stem Cell Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Canine Stem Cell Therapy Revenue Market Share by Application (2016-2021)
Table 29. Global Canine Stem Cell Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Canine Stem Cell Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Canine Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Canine Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Canine Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Canine Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Canine Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Canine Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Canine Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Canine Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Canine Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Canine Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Canine Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Canine Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Canine Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Canine Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Canine Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Canine Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Canine Stem Cell Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Canine Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Canine Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Canine Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Canine Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Canine Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Canine Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Canine Stem Cell Therapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Canine Stem Cell Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Canine Stem Cell Therapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Canine Stem Cell Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Canine Stem Cell Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. VETSTEM BIOPHARMA Company Details
Table 62. VETSTEM BIOPHARMA Business Overview
Table 63. VETSTEM BIOPHARMA Canine Stem Cell Therapy Product
Table 64. VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 65. VETSTEM BIOPHARMA Recent Development
Table 66. Cell Therapy Sciences Company Details
Table 67. Cell Therapy Sciences Business Overview
Table 68. Cell Therapy Sciences Canine Stem Cell Therapy Product
Table 69. Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 70. Cell Therapy Sciences Recent Development
Table 71. Regeneus Company Details
Table 72. Regeneus Business Overview
Table 73. Regeneus Canine Stem Cell Therapy Product
Table 74. Regeneus Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 75. Regeneus Recent Development
Table 76. Aratana Therapeutics Company Details
Table 77. Aratana Therapeutics Business Overview
Table 78. Aratana Therapeutics Canine Stem Cell Therapy Product
Table 79. Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 80. Aratana Therapeutics Recent Development
Table 81. Medivet Biologics Company Details
Table 82. Medivet Biologics Business Overview
Table 83. Medivet Biologics Canine Stem Cell Therapy Product
Table 84. Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 85. Medivet Biologics Recent Development
Table 86. Okyanos Company Details
Table 87. Okyanos Business Overview
Table 88. Okyanos Canine Stem Cell Therapy Product
Table 89. Okyanos Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 90. Okyanos Recent Development
Table 91. Vetbiologics Company Details
Table 92. Vetbiologics Business Overview
Table 93. Vetbiologics Canine Stem Cell Therapy Product
Table 94. Vetbiologics Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 95. Vetbiologics Recent Development
Table 96. VetMatrix Company Details
Table 97. VetMatrix Business Overview
Table 98. VetMatrix Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 99. VetMatrix Recent Development
Table 100. Magellan Stem Cells Company Details
Table 101. Magellan Stem Cells Business Overview
Table 102. Magellan Stem Cells Canine Stem Cell Therapy Product
Table 103. Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 104. Magellan Stem Cells Recent Development
Table 105. ANIMAL CELL THERAPIES Company Details
Table 106. ANIMAL CELL THERAPIES Business Overview
Table 107. ANIMAL CELL THERAPIES Canine Stem Cell Therapy Product
Table 108. ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 109. ANIMAL CELL THERAPIES Recent Development
Table 110. Stemcellvet Company Details
Table 111. Stemcellvet Business Overview
Table 112. Stemcellvet Canine Stem Cell Therapy Product
Table 113. Stemcellvet Revenue in Canine Stem Cell Therapy Business (2016-2021) & (US$ Million)
Table 114. Stemcellvet Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Stem Cell Therapy Market Share by Type: 2020 VS 2027
Figure 2. Allogeneic Stem Cells Features
Figure 3. Autologous Stem cells Features
Figure 4. Global Canine Stem Cell Therapy Market Share by Application: 2020 VS 2027
Figure 5. Veterinary Hospitals Case Studies
Figure 6. Veterinary Clinics Case Studies
Figure 7. Veterinary Research Institutes Case Studies
Figure 8. Canine Stem Cell Therapy Report Years Considered
Figure 9. Global Canine Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Canine Stem Cell Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Canine Stem Cell Therapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Canine Stem Cell Therapy Market Share by Regions (2022-2027)
Figure 13. Global Canine Stem Cell Therapy Market Share by Players in 2020
Figure 14. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Stem Cell Therapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Canine Stem Cell Therapy Revenue in 2020
Figure 16. Global Canine Stem Cell Therapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Canine Stem Cell Therapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Canine Stem Cell Therapy Market Share by Type (2016-2027)
Figure 20. North America Canine Stem Cell Therapy Market Share by Application (2016-2027)
Figure 21. North America Canine Stem Cell Therapy Market Share by Country (2016-2027)
Figure 22. United States Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Canine Stem Cell Therapy Market Share by Type (2016-2027)
Figure 26. Europe Canine Stem Cell Therapy Market Share by Application (2016-2027)
Figure 27. Europe Canine Stem Cell Therapy Market Share by Country (2016-2027)
Figure 28. Germany Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Canine Stem Cell Therapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Canine Stem Cell Therapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Canine Stem Cell Therapy Market Share by Region (2016-2027)
Figure 38. China Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Canine Stem Cell Therapy Market Share by Type (2016-2027)
Figure 46. Latin America Canine Stem Cell Therapy Market Share by Application (2016-2027)
Figure 47. Latin America Canine Stem Cell Therapy Market Share by Country (2016-2027)
Figure 48. Mexico Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Canine Stem Cell Therapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Canine Stem Cell Therapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Canine Stem Cell Therapy Market Share by Country (2016-2027)
Figure 54. Turkey Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Canine Stem Cell Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. VETSTEM BIOPHARMA Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 58. Cell Therapy Sciences Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 59. Regeneus Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 60. Aratana Therapeutics Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 61. Medivet Biologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 62. Okyanos Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 63. Vetbiologics Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 64. VetMatrix Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 65. Magellan Stem Cells Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 66. ANIMAL CELL THERAPIES Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 67. Stemcellvet Revenue Growth Rate in Canine Stem Cell Therapy Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の動物用幹細胞治療市場規模・現状・予測（2021年-2027年） Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three …- 世界の関節リウマチ幹細胞治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis stem cell therapy has been demonstrated to induce profound healing activity, halt arthritic conditions, and in many cases, reverse and regenerate joint tissue. Today, bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilica…
- 世界のがん幹細胞（CSC）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の自家幹細胞ベース治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界の変形性関節症幹細胞治療市場規模・現状・予測（2021年-2027年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…